A Comparison of Ultrasound-Guided Fine Needle Aspiration versus Core Needle Biopsy for Thyroid Nodules: Pain, Tolerability, and Complications

Eun Ji Jeong; Sae Rom Chung; Jung Hwan Baek; Young Jun Choi; Jae Kyun Kim; Jeong Hyun Lee

doi:10.3803/EnM.2018.33.1.114

Journal List > Endocrinol Metab > v.33(1) > 1095687

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Jeong, Chung, Baek, Choi, Kim, and Lee: A Comparison of Ultrasound-Guided Fine Needle Aspiration versus Core Needle Biopsy for Thyroid Nodules: Pain, Tolerability, and Complications

Original Article

Endocrinology and Metabolism 2018; 33(1): 114-120.

Published online: 21 March 2018

DOI: https://doi.org/10.3803/EnM.2018.33.1.114

A Comparison of Ultrasound-Guided Fine Needle Aspiration versus Core Needle Biopsy for Thyroid Nodules: Pain, Tolerability, and Complications

Eun Ji Jeong^1,^*, Sae Rom Chung^1,^*

, Jung Hwan Baek¹

, Young Jun Choi¹

, Jae Kyun Kim², Jeong Hyun Lee¹

¹Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

²Department of Radiology, Chung-Ang University College of Medicine, Seoul, Korea.

Corresponding author: Jung Hwan Baek. Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea. Tel: +82-2-3010-4348, Fax: +82-2-476-0090, radbaek@naver.com

Equal contributor:

*These authors contributed equally to this work.

Received 15 December 2017 Revised 3 January 2018 Accepted 18 January 2018

Korean Endocrine Society

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

To compare pain, tolerability, and complications associated with fine needle aspiration (FNA) versus core needle biopsy (CNB).

Methods

FNAs were performed using 23-gauge needles and CNBs were performed using 18-gauge double-action spring-activated needles in 100 patients for each procedure. Patients were asked to record a pain score using a 10-cm visual analog scale and procedure tolerability. Complications and number of biopsies were recorded.

Results

The median pain scores were similar for the FNA and CNB approaches during and 20 minutes after the biopsy procedures (3.7 vs. 3.6, P=0.454; 0.9 vs. 1.1, P=0.296, respectively). The procedure was tolerable in all 100 FNA patients and in 97 CNB patients (P=0.246). The mean number of biopsies was fewer in the CNB group (1.4 vs. 1.2, P=0.002). By subgroup analysis (staff vs. non-staff), no significant difference was detected in any parameter. There were no major complications in either group, but three patients who underwent CNB had minor complications (P=0.246).

Conclusion

FNA and CNB show no significant differences for diagnosing thyroid nodules in terms of pain, tolerability, or complications.

Keywords: Thyroid nodule, Biopsy, fine-needle, Biopsy, large-core needle, Safety

INTRODUCTION

Ultrasound (US)-guided fine needle aspiration (FNA) has been suggested to be a cost-effective and safe diagnostic procedure for assessing thyroid nodules and US-guided FNA has been established as the method of choice for this purpose [1]. However, FNA shows non-diagnostic results in 10% to 42% of cases [2 3 4], and atypia of undetermined significance or follicular lesions of undetermined cause in 3% to 18% of the thyroid nodules tested [4 5 6]. Despite these known limitations of FNA, the optimal management of these nodules has not yet been clearly established.

Recently, core needle biopsy (CNB) has been suggested as an alternative to FNA. CNB has shown efficacy for testing thyroid nodules that show non-diagnostic [7], or indeterminate [8 9] FNA results, and for clinically suspected lymphoma or anaplastic carcinoma [10]. Additionally, CNB is effective in the diagnosis of calcified thyroid nodules [11] and follicular neoplasms [12 13]. Although CNB has been suggested to be an effective procedure [14], assessments of its safety and tolerability in previous publications have been limited [15 16]. On our present study therefore we evaluated the pain, tolerability, and complications associated with CNB in comparison with FNA.

METHODS

Patients

This retrospective study was approved by the Institutional Review Board of Asan Medical Center (S2013-1765-0001) and informed consent was obtained from all patients before each procedure. From September to November 2013, 100 consecutive patients (male:female, 17:83; mean age, 51.3 years [range, 28 to 78]) who underwent FNA and 100 consecutive patients (male: female, 13:87; mean age, 49.7 years [range, 26 to 77]) who received CNB at our hospital (total cohort: male:female, 30:170; mean age, 50.5 years [range, 26 to 78]) were retrospectively evaluated.

US-guided FNA and CNB procedures

US examinations were performed using one of three systems: an iU 22 (Philips Medical Systems, Bothell, WA, USA); an EUB-7500 (Hitachi Medical Systems, Tokyo, Japan); or an Aixplorer (Super Sonic Imagine S.A., Aix-en-Provence, France) equipped with a linear, high frequency probe (5 to 14 MHz). All US examinations and US-guided FNA or CNB procedures were performed by experienced staff, and by non-staff (fellows, or resident radiologists) under the supervision of two experienced thyroid radiologists with 18 and 12 years of thyroid US experience, respectively. Whether to perform CNB or FNA was determined according to the referring physicians' preference. After evaluation of thyroid and perithyroidal structures, including the vessels or esophagus, we measured the size of the nodule [17]. FNAs were performed using a 10-mL plastic syringe attached to a conventional 23-gauge needle with a combination of capillary and aspiration techniques that were selected according to the nodule characteristics. No local anesthesia was performed before performing FNA. US-guided CNB was performed using a disposable 18-gauge double-action spring-activated needle (1.1- or 1.6-cm excursion; TSK Ace-cut, Create Medic, Yokohama, Japan). Local anesthesia with 1% lidocaine was selectively performed before performing CNB [7 9 18]. Using a freehand technique, the core of the needle was advanced from the isthmus of the thyroid towards the target nodule using the transisthmic approach [19]. When the needle tip was advanced into the edge of the nodule, the stylet and cutting cannula of the needle were sequentially fired. A second FNA or CNB was performed when adequate tissue was not obtained based on a visual inspection [7 9 20]. The number of biopsies and types of core needles were recorded in our radiology US-guided biopsy report.

Questionnaire

Immediately after the FNA or CNB procedure, patients were asked by one author to rate their pain on a 10-cm visual analog scale (0 to 10 cm) with “0” representing “no pain” and “10” representing the “the worst pain imaginable.” After compression of the biopsy site for 20 minutes, patients were asked again to rate their pain on a 10-cm visual analog scale (0 to 10 cm) and also whether the procedure was tolerable or not.

Statistical analyses

Statistical analyses were performed using SPSS version 18.0 for Windows (SPSS Inc., Chicago, IL, USA). We analyzed and compared parameters that included pain score, the number of biopsies, complications, tolerability, and non-diagnostic pathological results between the FNA and CNB groups. We also performed subgroup analyses between staff and non-staff groups. The chi-square test or Fisher exact test for categorical variables and the Mann-Whitney U test for quantitative variables were used to compare study groups. Statistical significance was accepted for P<0.05.

RESULTS

All patients underwent FNA or CNB for one nodule respectively. All 200 patients also completed questionnaires to evaluate the level of pain associated with FNA or CNB. Both staff and non-staff performed the FNA (75 by non-staff, 25 by staff) or CNB (30 by non-staff, 70 by staff) procedures.

Demographic data for the patients who underwent FNA or CNB are summarized in Table 1. There were no significant differences in either gender or age between the two groups (P=0.553 and P=0.318, respectively). The mean size of nodules of FNA group was statistically significantly smaller than that of CNB group (1.2 cm vs. 1.7 cm, P<0.001). However, the number of nodules <1 cm between the FNA and CNB patients showed no significant difference (46 vs. 40, P=0.475).

Table 2 details the questions and patient responses following both FNA and CNB procedures. Regarding the mean pain score during and at 20 minutes after the procedures, there were no significant differences between the two groups (3.7 vs. 3.6, P=0.454; 0.9 vs. 1.1, P=0.296, respectively). Regarding procedure-related complications and tolerability, there was also no difference detected between the groups. Regarding the mean number of biopsies, this was greater in the FNB group (1.4 vs. 1.2, P=0.002). Although we detected a tendency for FNA to be more frequently associated with non-diagnostic pathological results than CNB, this was not significant (5 vs. 0, P=0.059).

We performed subgroup analysis stratified by staff and nonstaff (Table 3). There were no significant differences for any parameter analyzed for the two biopsy methods, including pain score, biopsy number, tolerability, complications, and non-diagnostic pathological results. However, the number of biopsies for non-staff was less than that for staff in the FNA group (P=0.04).

Complications

There were no major complications in either the FNA or CNB groups, and no patient required hospital admission or interventional treatment. In the case of the CNB group, there were three minor complications, including perithyroidal hemorrhage and parenchyma edema; however, there were no significant differences with regard to this parameter between the groups (P=0.246). In the patients with hemorrhage and parenchymal edema, the symptoms were relieved following manual compression from 30 minutes to 2 hours. After compression, US evaluations showed the nearly complete disappearance of the hematoma or edema. There have been no delayed complications reported during the follow-up period in our current patient series.

DISCUSSION

We observed no significant differences in terms of pain, tolerability, or complications between the FNA and CNB procedures. The rate of non-diagnostic pathologic result was lower in CNB, even though CNB achieved a fewer number of biopsies than FNA. In our subgroup analysis (staff vs. non-staff), we detected no significant difference in any parameter in terms of efficacy or safety. Our present findings thus suggest that FNA and CNB are equivalent in terms of pain, tolerability, and possible complications.

Two previous studies have also compared the tolerability of FNA versus CNB [15 16] and suggested that the two procedures are similar in terms of tolerability and pain. Nasrollah et al. [16] found that the occurrence of pain during the first few minutes following CNB was significantly higher than FNA, although there was no significant difference in pain detected at later time points for either procedure. The patients in that study were asked to evaluate the degree of tolerability for both procedures, and no significant difference was reported. Stangierski et al. [15] reported that CNB was slightly more painful than FNA but remained tolerable for most patients. In our present study, we found no differences in either pain or tolerability for either procedure during and at 20 minutes after the biopsy. We further found that CNB required fewer numbers of biopsies than FNA. Considering the different experience level of the staff versus non-staff who performed these procedures, we also performed subgroup analysis, but again found no significant differences in terms of pain, tolerability, or complications for both procedures.

In recent studies, CNB using 18 to 22 gauges cutting needles with US guidance has allowed operators to obtain thyroid tissue samples without major complications. From 1994 to 2014, many CNB studies have reported associated complications (Table 4) [7 8 9 11 12 16 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40,41]. The total number of nodules reported in that period was 4,201, for which there were 60 recorded complications (1.43%) including hematoma, parenchyma edema, hemoptysis, infection, hoarseness, vasovagal reaction, and dysphagia. Hematoma was the most common complication, which was reported in 35/4,201 cases (0.83%). There were three patients described with minor soft tissue infections after CNB that were successfully managed by orally administered antibiotics. In our present study, only three of the cases in the CNB series (3%) experienced minor hematoma after the procedure and there was no significant difference in the complication rate between the FNA and CNB groups. All of the reported symptoms among our current study subjects were mild and recovery occurred in all cases with simple compression within 2 hours. Furthermore, additional treatments or hospitalization were unnecessary in these cases. Although CNB showed no major complications and similar pain or discomfort when compared with FNA in our study, it remains important for investigators to understand the anatomy of the thyroid and perithyroidal areas to minimize adverse events after either procedure [19].

In terms of the advantages of CNB, it provides a larger tissue sample and can facilitate a more precise histological diagnosis. At the microscopic level, the core of the CNB nodule sample offers the possibility of evaluating the general architecture of the lesion, alterations of the follicular structures, and the integrity of the capsule of the nodule along with its relationship with adjacent tissues. Specifically, CNB core samples allow for the differentiation of cancer in up to 98% of thyroid nodules that showed previously indeterminate FNA results [8]. Additionally, Na et al. [7] reported that CNB is more useful for reducing the number of inconclusive diagnoses than FNA, and that this method will serve a useful complementary diagnostic role for the optimal management of thyroid nodules with previous non-diagnostic findings or atypia from FNA readings. The devices and techniques associated CNB have been developed over the past 20 years. Unlike the old technique of palpation-guided large needle biopsy, US-guided CNB, using a modern spring-activated biopsy needle, has been reported to be a safe and well tolerated procedure [16 21 22]. Furthermore, the guidelines of the National Cancer Institute [14] also suggest that CNB is safe, well tolerated, and associated with a low incidence of complications.

Our study had several limitations of note. First, it was retrospective in design, which could have introduced an inherent bias regarding patient selection. However, all patients were consecutively enrolled. Second, multiple operators with different levels of experience were involved. However, the inclusion of multiple operators reflects the real practice in our hospital and we performed subgroup analysis between staff and non-staff. Third, we used relatively small sample size to assess the low incidence of complication of FNA and CNB. Although CNB has been known as a safe procedure [42 43 44], a further prospective investigation with a larger sample size is necessary to verify the results of our study. Finally, we performed local anesthesia with 2% lidocaine when performing the CNB procedure, but not with FNA procedure. It can be influence the pain score of the patients who underwent CNB procedure. However, 70% of patients, who underwent CNB by staff, did not undergo local anesthesia. Thus majority of patients who underwent CNB actually did not have received local anesthesia.

In conclusion, FNA and CNB show no significant differences in terms of pain, tolerability, or complications for diagnosing thyroid nodules.

Figures and Tables

Table 1

Demographic Data for the FNA and CNB Patients

Characteristic	FNA (n=100)	CNB (n=100)	P value
Sex, male/female	17/83	13/87	0.553
Age, yr	51.3±11.3 (28–78)	49.7±10.9 (26–77)	0.318
Nodule size, cm	1.2±0.7 (0.3–4.1)	1.7±1.2 (0.3–5.1)	<0.001
No. of nodule, size <1 cm	46	40	0.475

Values are expressed as mean±SD (range).

FNA, fine needle aspiration; CNB, core needle biopsy.

Table 2

Comparison of the Indicated Parameters between the FNA and CNB Groups

Variable	FNA (n=100)	CNB (n=100)	P value
Pain score
During biopsy	3.7 (0–10)	3.6 (0–8)	0.454
After 20 min	0.9 (0–8)	1.1 (0–8)	0.296
No. of biopsies	1.4 (1–3)	1.2 (1–3)	0.002
Tolerability			0.246
Yes	100	97
No	0	0
Complication	0	3	0.246
Non-diagnostic	5	0	0.059

Values are expressed as median (range).

FNA, fine needle aspiration; CNB, core needle biopsy.

Table 3

Comparison of Staff vs. Non-Staff Subjects

Variable	FNA			CNB
Variable	Staff	Non-staff	P value	Staff	Non-staff	P value
Pain score
During biopsy	3.3	3.8	0.272	3.6	3.0	0.14
After 20 min	0.5	1.0	0.125	1.3	0.8	0.14
No. of biopsies	1.5	1.3	0.04	1.1	1.2	0.306
Tolerability
Yes	25/25	75/75	>0.99	3/70	0/30	0.552
No	0/25	0/75		67/70	30/30
Complication	0/25	0/75	>0.99	3/70	0/30	0.552
Non-diagnostic	1/25	4/75	>0.99	0/70	0/30	>0.99

FNA, fine needle aspiration; CNB, core needle biopsy.

Table 4

Previously Reported Complications for Ultrasound-Guided Core Needle Biopsy

Study	No. of nodule	Hematoma	Edema	Hemoptysis	Infection	Hoarseness	Vasovagal reaction	Dysphagia	Total
Quinn et al. (1994) [21]	102				1				1
Liu et al. (1995) [22]	100								0
Taki et al. (1997) [23]	74								0
Pisani et al. (2001) [24]	32								0
Screaton et al. (2003) [25]	209	3		1					4
Harvey et al. (2005) [26]	79								0
Renshaw et al. (2007) [27]	377	1							1
Strauss et al. (2008) [28]	81								0
Zhang et al. (2008) [29]	225								0
Khoo et al. (2008) [30]	359	8			2		2	1	13
Park et al. (2011) [8]	54					1			1
Samir et al. (2012) [31]	90								0
Sung et al. (2012) [32]	555	11	9						20
Na et al. (2012) [7]	225	5	3						8
Yunker et al. (2013) [33]	74								0
Yeon et al. (2013) [9]	155	1	2						3
Hahn et al. (2013) [34]	88								0
Nasrollah et al. (2013) [35]	40								0
Ha et al. (2013) [36]	85								0
Hakala et al. (2013) [37]	52								0
Lee et al. (2014) [38]	125								0
Choi et al. (2014) [39]	191	1							1
Nasrollah et al. (2014) [16]	61	1							1
Trimboli et al. (2014) [40]	31								0
Zhang et al. (2014) [41]	369	2				2			4
Min et al. (2014) [12]	104								0
Ha et al. (2014) [11]	264	2	1						3
Total	4,201	35	15	1	3	3	2	1	60

Notes

^{CONFLICTS OF INTEREST} No potential conflict of interest relevant to this article was reported.

^{AUTHOR CONTRIBUTIONS} Conception or design: J.H.B., E.J.J., Y.J.C., J.H.L., J.K.K., S.R.C. Acquisition, analysis, or interpretation of data: J.H.B., E.J.J., S.R.C. Drafting the work or revising: J.H.B., E.J.J., S.R.C. Final approval of the manuscript: J.H.B., E.J.J., Y.J.C., J.H.L., J.K.K., S.R.C. Statistical analysis: J.K.K.

References

1. Lee YH, Baek JH, Jung SL, Kwak JY, Kim JH, Shin JH, et al. Ultrasound-guided fine needle aspiration of thyroid nodules: a consensus statement by the Korean Society of Thyroid Radiology. Korean J Radiol. 2015; 16:391–401.

2. Alexander EK, Heering JP, Benson CB, Frates MC, Doubilet PM, Cibas ES, et al. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab. 2002; 87:4924–4927.

3. Orija IB, Pineyro M, Biscotti C, Reddy SS, Hamrahian AH. Value of repeating a nondiagnostic thyroid fine-needle aspiration biopsy. Endocr Pract. 2007; 13:735–742.

4. Yang J, Schnadig V, Logrono R, Wasserman PG. Fine-needle aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007; 111:306–315.

5. Nayar R, Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer. 2009; 117:195–202.

6. Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007; 111:508–516.

7. Na DG, Kim JH, Sung JY, Baek JH, Jung KC, Lee H, et al. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology. Thyroid. 2012; 22:468–475.

8. Park KT, Ahn SH, Mo JH, Park YJ, Park DJ, Choi SI, et al. Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules. Head Neck. 2011; 33:160–165.

9. Yeon JS, Baek JH, Lim HK, Ha EJ, Kim JK, Song DE, et al. Thyroid nodules with initially nondiagnostic cytologic results: the role of core-needle biopsy. Radiology. 2013; 268:274–280.

10. Ha EJ, Baek JH, Lee JH, Kim JK, Song DE, Kim WB, et al. Core needle biopsy could reduce diagnostic surgery in patients with anaplastic thyroid cancer or thyroid lymphoma. Eur Radiol. 2016; 26:1031–1036.

11. Ha EJ, Baek JH, Lee JH, Kim JK, Kim JK, Lim HK, et al. Core needle biopsy can minimise the non-diagnostic results and need for diagnostic surgery in patients with calcified thyroid nodules. Eur Radiol. 2014; 24:1403–1409.

12. Min HS, Kim JH, Ryoo I, Jung SL, Jung CK. The role of core needle biopsy in the preoperative diagnosis of follicular neoplasm of the thyroid. APMIS. 2014; 122:993–1000.

13. Yoon RG, Baek JH, Lee JH, Choi YJ, Hong MJ, Song DE, et al. Diagnosis of thyroid follicular neoplasm: fine-needle aspiration versus core-needle biopsy. Thyroid. 2014; 24:1612–1617.

14. Baloch ZW, Cibas ES, Clark DP, Layfield LJ, Ljung BM, Pitman MB, et al. The National Cancer Institute thyroid fine needle aspiration state of the science conference: a summation. Cytojournal. 2008; 5:6.

15. Stangierski A, Wolinski K, Martin K, Leitgeber O, Ruchala M. Core needle biopsy of thyroid nodules: evaluation of diagnostic utility and pain experience. Neuro Endocrinol Lett. 2013; 34:798–801.

16. Nasrollah N, Trimboli P, Rossi F, Amendola S, Guidobaldi L, Ventura C, et al. Patient's comfort with and tolerability of thyroid core needle biopsy. Endocrine. 2014; 45:79–83.

17. Choi YJ, Baek JH, Hong MJ, Lee JH. Inter-observer variation in ultrasound measurement of the volume and diameter of thyroid nodules. Korean J Radiol. 2015; 16:560–565.

18. Shin JH, Baek JH, Chung J, Ha EJ, Kim JH, Lee YH, et al. Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of Thyroid Radiology consensus statement and recommendations. Korean J Radiol. 2016; 17:370–395.

19. Ha EJ, Baek JH, Lee JH. Ultrasonography-based thyroidal and perithyroidal anatomy and its clinical significance. Korean J Radiol. 2015; 16:749–766.

20. Moon WJ, Baek JH, Choi JW, Kim YJ, Ha EJ, Lim HK, et al. The value of gross visual assessment of specimen adequacy for liquid-based cytology during ultrasound-guided, fine-needle aspiration of thyroid nodules. Endocr Pract. 2015; 21:1219–1226.

21. Quinn SF, Nelson HA, Demlow TA. Thyroid biopsies: fine-needle aspiration biopsy versus spring-activated core biopsy needle in 102 patients. J Vasc Interv Radiol. 1994; 5:619–623.

22. Liu Q, Castelli M, Gattuso P, Prinz RA. Simultaneous fineneedle aspiration and core-needle biopsy of thyroid nodules. Am Surg. 1995; 61:628–632.

23. Taki S, Kakuda K, Kakuma K, Annen Y, Katada S, Yamashita R, et al. Thyroid nodules: evaluation with US-guided core biopsy with an automated biopsy gun. Radiology. 1997; 202:874–877.

24. Pisani T, Bononi M, Nagar C, Angelini M, Bezzi M, Vecchione A. Fine needle aspiration and core needle biopsy techniques in the diagnosis of nodular thyroid pathologies. Anticancer Res. 2000; 20(5C):3843–3847.

25. Screaton NJ, Berman LH, Grant JW. US-guided core-needle biopsy of the thyroid gland. Radiology. 2003; 226:827–832.

26. Harvey JN, Parker D, De P, Shrimali RK, Otter M. Sonographically guided core biopsy in the assessment of thyroid nodules. J Clin Ultrasound. 2005; 33:57–62.

27. Renshaw AA, Pinnar N. Comparison of thyroid fine-needle aspiration and core needle biopsy. Am J Clin Pathol. 2007; 128:370–374.

28. Strauss EB, Iovino A, Upender S. Simultaneous fine-needle aspiration and core biopsy of thyroid nodules and other superficial head and neck masses using sonographic guidance. AJR Am J Roentgenol. 2008; 190:1697–1699.

29. Zhang S, Ivanovic M, Nemcek AA Jr, Defrias DV, Lucas E, Nayar R. Thin core needle biopsy crush preparations in conjunction with fine-needle aspiration for the evaluation of thyroid nodules: a complementary approach. Cancer. 2008; 114:512–518.

30. Khoo TK, Baker CH, Hallanger-Johnson J, Tom AM, Grant CS, Reading CC, et al. Comparison of ultrasound-guided fine-needle aspiration biopsy with core-needle biopsy in the evaluation of thyroid nodules. Endocr Pract. 2008; 14:426–431.

31. Samir AE, Vij A, Seale MK, Desai G, Halpern E, Faquin WC, et al. Ultrasound-guided percutaneous thyroid nodule core biopsy: clinical utility in patients with prior nondiagnostic fine-needle aspirate. Thyroid. 2012; 22:461–467.

32. Sung JY, Na DG, Kim KS, Yoo H, Lee H, Kim JH, et al. Diagnostic accuracy of fine-needle aspiration versus core-needle biopsy for the diagnosis of thyroid malignancy in a clinical cohort. Eur Radiol. 2012; 22:1564–1572.

33. Yunker WK, Hassan SF, Ferrell LB, Hicks MJ, Giannoni CM, Wesson DE, et al. Needle core biopsy in the diagnosis of pediatric thyroid neoplasms: a single institution retrospective review. Pediatr Surg Int. 2013; 29:437–443.

34. Hahn SY, Shin JH, Han BK, Ko EY, Ko ES. Ultrasonography-guided core needle biopsy for the thyroid nodule: does the procedure hold any benefit for the diagnosis when fineneedle aspiration cytology analysis shows inconclusive results? Br J Radiol. 2013; 86:20130007.

35. Nasrollah N, Trimboli P, Guidobaldi L, Cicciarella Modica DD, Ventura C, Ramacciato G, et al. Thin core biopsy should help to discriminate thyroid nodules cytologically classified as indeterminate. A new sampling technique. Endocrine. 2013; 43:659–665.

36. Ha EJ, Baek JH, Lee JH, Song DE, Kim JK, Shong YK, et al. Sonographically suspicious thyroid nodules with initially benign cytologic results: the role of a core needle biopsy. Thyroid. 2013; 23:703–708.

37. Hakala T, Kholova I, Sand J, Saaristo R, Kellokumpu-Lehtinen P. A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy. J Clin Pathol. 2013; 66:1046–1050.

38. Lee SH, Kim MH, Bae JS, Lim DJ, Jung SL, Jung CK. Clinical outcomes in patients with non-diagnostic thyroid fine needle aspiration cytology: usefulness of the thyroid core needle biopsy. Ann Surg Oncol. 2014; 21:1870–1877.

39. Choi YJ, Baek JH, Ha EJ, Lim HK, Lee JH, Kim JK, et al. Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy. Thyroid. 2014; 24:494–501.

40. Trimboli P, Nasrollah N, Guidobaldi L, Taccogna S, Cicciarella Modica DD, Amendola S, et al. The use of core needle biopsy as first-line in diagnosis of thyroid nodules reduces false negative and inconclusive data reported by fine-needle aspiration. World J Surg Oncol. 2014; 12:61.

41. Zhang M, Zhang Y, Fu S, Lv F, Tang J. Thyroid nodules with suspicious ultrasound findings: the role of ultrasoundguided core needle biopsy. Clin Imaging. 2014; 38:434–438.

42. Jung CK, Baek JH. Recent advances in core needle biopsy for thyroid nodules. Endocrinol Metab (Seoul). 2017; 32:407–412.

43. Na DG, Baek JH, Jung SL, Kim JH, Sung JY, Kim KS, et al. Core needle biopsy of the thyroid: 2016 consensus statement and recommendations from Korean Society of Thyroid Radiology. Korean J Radiol. 2017; 18:217–237.

44. Baek JH. Current status of core needle biopsy of the thyroid. Ultrasonography. 2017; 36:83–85.

TOOLS

ORCID iDs

Sae Rom Chung
https://orcid.org/0000-0003-4219-7166

Jung Hwan Baek
https://orcid.org/0000-0003-0480-4754

Young Jun Choi
https://orcid.org/0000-0001-7098-5042

Jeong Hyun Lee
https://orcid.org/0000-0002-0021-4477

Similar articles